Boston Scientific's total assets for Q3 2024 were $38.08B, an increase of 2.61% from the previous quarter. BSX total liabilities were $17.12B for the fiscal quarter, a 3.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.